Related Experiment Videos
Anaplasia and grading in medulloblastomas
Charles G Eberhart1, Peter C Burger
1Department of Pathology, Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA. ceberha@jhmi.edu
Brain Pathology (Zurich, Switzerland)
|August 30, 2003
Summary
Histopathological grading of medulloblastoma, a pediatric brain tumor, aids in tailoring treatments. Anaplastic features indicate higher malignancy and poorer outcomes, guiding personalized patient care.
Area of Science:
- Neuro-oncology
- Pediatric Pathology
- Cancer Genomics
Background:
- Medulloblastoma exhibits variable clinical outcomes, necessitating personalized treatment strategies.
- Histopathological features, particularly anaplasia, are crucial for understanding medulloblastoma progression.
Purpose of the Study:
- To review clinical, histological, and molecular features for medulloblastoma treatment customization.
- To highlight the impact of histopathological grading on patient care and research.
Main Methods:
- Review of clinical data, histological classifications, and molecular alterations in medulloblastoma.
- Analysis of the correlation between histological changes and genetic events.
Main Results:
- Medulloblastomas range histologically, with high-grade anaplastic lesions showing increased malignancy.
- High-grade lesions (approx. 25%) recur and metastasize more frequently.
- Anaplastic change is proposed as a common malignant progression pathway across medulloblastoma subtypes.
Conclusions:
- Histopathological grading is essential for personalized medulloblastoma treatment.
- Anaplastic features signify a critical step in medulloblastoma progression.
- A model for histological and molecular progression is suggested, integrating genetic events.